Market Vectors ETF Trust has distributed the quarterly dividend for its Pharmaceutical ETF (PPH), an exchange-traded fund which seeks to track an index comprised of the largest, most liquid global pharmaceutical companies.
PPH distributed USD0.2684 per share for the second quarter. The payable date was 8 July.
“PPH continues to offer investors a single point of access to the largest names in global pharma and the attractive dividends they have historically paid,” says Mike Cohick, ETF product manager with Market Vectors. “The pharma growth story continues to be compelling and the income potential of the constituents in the index may continue to interest investors as we head into the second half of the year.”
PPH seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index, a rules-based index intended to track the overall performance of the largest 25 US-listed pharmaceutical companies. The index methodology favours the largest, most liquid companies in the industry and the portfolio may include both domestic and US-listed foreign companies, allowing for enhanced industry representation.
